Amplify Seymour Cannabis ETF (CNBS)
- Previous Close
17.01 - Open
17.09 - Bid 17.21 x 4000
- Ask 17.26 x 4000
- Day's Range
17.08 - 17.23 - 52 Week Range
4.09 - 64.96 - Volume
3,791 - Avg. Volume
27,832 - Net Assets 80.77M
- NAV 17.18
- PE Ratio (TTM) --
- Yield 52.88%
- YTD Daily Total Return -31.34%
- Beta (5Y Monthly) 1.23
- Expense Ratio (net) 0.76%
Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund’s investment adviser, Amplify Investments LL. Pursuant to this strategy, it will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.
Amplify ETFs
Fund Family
Miscellaneous Sector
Fund Category
80.77M
Net Assets
2019-07-15
Inception Date
Performance Overview: CNBS
View MoreTrailing returns as of 5/16/2025. Category is Miscellaneous Sector.
People Also Watch
Holdings: CNBS
View MoreTop 4 Holdings (22.44% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: CNBS
View MoreCuraleaf Earnings: Price Compression Continues to Weigh on Top-Line Growth and Hits Margin
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
RatingPrice TargetGreen Thumb Earnings: Price Compression Weighs; Shares Undervalued but Uncertainty Very High
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice TargetCuraleaf Offers Unique Investment Exposure to Both International Medical and American Cannabis
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
RatingPrice TargetGreen Thumb's Growth Should Benefit From Easing Federal Prohibition and New State Legalizations
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice Target